Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MARK A DAVIS-LORTON

Allopathic & Osteopathic Physicians Allergy & Immunology

NPI
1396727665
CMS profile
1114745
Location
TARRYTOWN, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$23,215.66

114 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

By paying entity

PY2023 · entire year · sorted by reported total

Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MARK A DAVIS-LORTON

NPI 1396727665 · CMS profile ID 1114745

Allopathic & Osteopathic Physicians / Allergy & Immunology

TARRYTOWN, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1396727665?year=2023&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MARK A DAVIS-LORTON, NPI 1396727665, CMS profile ID 1114745. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1396727665?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). MARK A DAVIS-LORTON, NPI 1396727665, CMS profile ID 1114745. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1396727665?year=2023&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
MARK A DAVIS-LORTON, NPI 1396727665, CMS profile ID 1114745, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 3; records 51–100 of 114 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1396727665?year=2023&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

114 matching records · $23,215.66 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 114 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 114.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
CSL Behring $22.8807/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043019449 CMS
Pharming Healthcare, Inc. $24.1807/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1029328851 CMS
AstraZeneca Pharmaceuticals LP $12.8407/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012043509 CMS
GlaxoSmithKline, LLC. $5.9007/11/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002117865 CMS
SANOFI-AVENTIS U.S. LLC $89.9907/10/2023 Education No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049812397 CMS
BioCryst US Sales Co., LLC $19.4207/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012562049 CMS
GENZYME CORPORATION $22.9406/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049812403 CMS
BioCryst US Sales Co., LLC $17.7906/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012562033 CMS
GlaxoSmithKline, LLC. $5.6906/21/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002117855 CMS
Incyte Corporation $28.2706/20/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1044478753 CMS
CSL Behring $26.8406/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043019411 CMS
Novartis Pharmaceuticals Corporation $19.1106/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 991729395 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.8606/07/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055375659 CMS
BioCryst US Sales Co., LLC $11.6505/31/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012562011 CMS
Pharming Healthcare, Inc. $22.5905/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1029328843 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,251.2505/25/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055375657 CMS
AstraZeneca Pharmaceuticals LP $17.5105/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011698201 CMS
GlaxoSmithKline, LLC. $15.7405/23/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002117809 CMS
Takeda Pharmaceuticals U.S.A., Inc. $302.0605/19/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055375655 CMS
Takeda Pharmaceuticals U.S.A., Inc. $50.0005/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061744969 CMS
Takeda Pharmaceuticals U.S.A., Inc. $30.0005/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061744971 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.0005/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061744973 CMS
Takeda Pharmaceuticals U.S.A., Inc. $65.0005/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061744975 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.0005/19/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1061744977 CMS
Takeda Pharmaceuticals U.S.A., Inc. $324.9005/18/2023 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055375653 CMS
CSL Behring $14.8805/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043019207 CMS
Genentech USA, Inc. $16.8005/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1040450445 CMS
BioCryst US Sales Co., LLC $21.6605/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012562007 CMS
Hikma Pharmaceuticals USA $17.5405/08/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1053748821 CMS
CSL Behring $24.2005/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043019169 CMS
GENZYME CORPORATION $14.1504/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049812359 CMS
Pharming Healthcare, Inc. $4,200.0004/25/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1029328826 CMS
Pharming Healthcare, Inc. $190.0104/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1029328833 CMS
GlaxoSmithKline, LLC. $5.9004/17/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002117877 CMS
Optinose US, Inc. $13.6704/14/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1035206995 CMS
GlaxoSmithKline, LLC. $7.3103/29/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002117785 CMS
CSL Behring $20.5503/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043019141 CMS
GlaxoSmithKline, LLC. $10.7603/22/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002117935 CMS
Pharming Healthcare, Inc. $2,000.0003/15/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1029328819 CMS
Optinose US, Inc. $17.7803/06/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1035206957 CMS
AstraZeneca Pharmaceuticals LP $20.2803/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1011970431 CMS
CSL Behring $15.4803/03/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1043019123 CMS
BioCryst US Sales Co., LLC $11.2402/28/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012561661 CMS
GENZYME CORPORATION $32.5402/25/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049812335 CMS
BioCryst US Sales Co., LLC $33.6502/24/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012561673 CMS
Takeda Pharmaceuticals U.S.A., Inc. $2.0702/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055375647 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1.1702/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055375649 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.8402/15/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1055375651 CMS
BioCryst US Sales Co., LLC $550.0002/13/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1012561597 CMS
GENZYME CORPORATION $4.7402/13/2023 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1049812305 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $21,236.00 104
PY2020 $17,192.22 93
PY2021 $18,264.90 62
PY2022 $45,678.28 127
PY2023 $23,215.66 114
PY2024 $57,498.46 105
PY2025 $22,956.74 79

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2019 Principal investigator $159,093.90 11

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

11 records in PY2019

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Shire North American Group Inc $1,130.40 10/09/2019 Covered Recipient Teaching Hospital
NYU WINTHROP HOSPITAL
HELP STUDY EXTENSIONTM AN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF DX-2930 FOR PREVENTION AGAINST ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA HAE No dispute reported 06/30/2026 637705455
Principal investigator 1 Shire North American Group Inc $6,874.20 08/14/2019 Covered Recipient Teaching Hospital
NYU WINTHROP HOSPITAL
HELP STUDY EXTENSIONTM AN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF DX-2930 FOR PREVENTION AGAINST ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA HAE No dispute reported 06/30/2026 637705453
Principal investigator 1 Shire North American Group Inc $1,789.20 07/16/2019 Covered Recipient Teaching Hospital
NYU WINTHROP HOSPITAL
HELP STUDY EXTENSIONTM AN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF DX-2930 FOR PREVENTION AGAINST ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA HAE No dispute reported 06/30/2026 637705449
Principal investigator 1 Shire North American Group Inc $5,755.50 07/16/2019 Covered Recipient Teaching Hospital
NYU WINTHROP HOSPITAL
HELP STUDY EXTENSIONTM AN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF DX-2930 FOR PREVENTION AGAINST ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA HAE No dispute reported 06/30/2026 637705451
Principal investigator 1 Shire North American Group Inc $22,361.40 06/12/2019 Covered Recipient Teaching Hospital
NYU WINTHROP HOSPITAL
HELP STUDY EXTENSIONTM AN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF DX-2930 FOR PREVENTION AGAINST ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA HAE No dispute reported 06/30/2026 637705445
Principal investigator 1 Shire North American Group Inc $22,500.00 06/12/2019 Covered Recipient Teaching Hospital
NYU WINTHROP HOSPITAL
HELP STUDY EXTENSIONTM AN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF DX-2930 FOR PREVENTION AGAINST ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA HAE No dispute reported 06/30/2026 637705447
Principal investigator 1 Shire North American Group Inc $20,143.80 05/15/2019 Covered Recipient Teaching Hospital
NYU WINTHROP HOSPITAL
HELP STUDY EXTENSIONTM AN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF DX-2930 FOR PREVENTION AGAINST ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA HAE No dispute reported 06/30/2026 637705439
Principal investigator 1 Shire North American Group Inc $17,449.20 04/10/2019 Covered Recipient Teaching Hospital
NYU WINTHROP HOSPITAL
HELP STUDY EXTENSIONTM AN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF DX-2930 FOR PREVENTION AGAINST ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA HAE No dispute reported 06/30/2026 637705437
Principal investigator 1 Shire North American Group Inc $19,890.90 03/12/2019 Covered Recipient Teaching Hospital
NYU WINTHROP HOSPITAL
HELP STUDY EXTENSIONTM AN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF DX-2930 FOR PREVENTION AGAINST ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA HAE No dispute reported 06/30/2026 637705435
Principal investigator 1 Shire North American Group Inc $21,106.80 02/13/2019 Covered Recipient Teaching Hospital
NYU WINTHROP HOSPITAL
HELP STUDY EXTENSIONTM AN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF DX-2930 FOR PREVENTION AGAINST ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA HAE No dispute reported 06/30/2026 637705427
Principal investigator 1 Shire North American Group Inc $20,092.50 01/09/2019 Covered Recipient Teaching Hospital
NYU WINTHROP HOSPITAL
HELP STUDY EXTENSIONTM AN OPEN-LABEL STUDY TO EVALUATE THE LONG-TERM SAFETY AND EFFICACY OF DX-2930 FOR PREVENTION AGAINST ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA HAE No dispute reported 06/30/2026 637705425